Technion Seed

Vinesight is a developer of a media analysis platform focused on identifying and combating misinformation and fake news on social media. Utilizing advanced artificial intelligence technology, the platform is designed to operate in a content-agnostic manner, allowing it to analyze a wide range of information across different networks. Vinesight provides clients with deep behavioral science insights, enabling them to swiftly detect viral misinformation and manage potential threats to their brand's reputation. Through its innovative approach, Vinesight aims to create accountability in the sharing of digital information.

Aren, Inc. is a New York-based company that has developed an artificial intelligence-powered platform aimed at enhancing the assessment and management of civil infrastructure. The platform employs data-driven decision-making and risk management techniques to minimize the potential for infrastructure failure while optimizing budget allocations for global infrastructure projects. Utilizing advanced technologies such as computer vision and machine learning, Aren provides a cost-effective and automated approach to asset management, enabling engineers and asset owners to make informed decisions and effectively manage risks associated with their infrastructure assets.

Envizion Medical develops electromagnetic feeding tube placement devices, including the ENvue System, which uses multiple sensors and anatomical landmarks to create an image map of a patient's upper GI tract and guide the feeding tube to the correct location. The system provides bedside vision of placement, improving accuracy, enabling faster initiation of feeding, and potentially shortening ICU stays for patients who require enteral nutrition. Based in Tel Aviv, Israel, the company focuses on patient safety and outcomes through navigation technology for feeding tubes across the continuum of care.

Aleph Farms Limited is an innovative food technology company based in Ashdod, Israel, specializing in cellular agriculture to produce clean meat. Founded in 2017, Aleph Farms focuses on sustainable food production by developing methods to grow animal products directly from non-genetically modified animal cells, utilizing proprietary three-dimensional bioprinting technologies. The company made significant strides in the industry by unveiling the world's first cultivated thin-cut steak in 2018, followed by the first cultivated ribeye steak in 2021 and cultivated collagen in 2022. Under its product brand Aleph Cuts, its inaugural offering, the Petit Steak, is crafted from non-modified cells sourced from a premium Angus cow, allowing production without animal slaughter. Aleph Farms has garnered recognition for its commitment to climate leadership, including a net zero pledge made in 2020, earning accolades from prominent organizations like the World Economic Forum and the United Nations.

DigiFlex Ltd. is a manufacturer of innovative inkjet printing systems, specializing in the production of photopolymer flexographic, letterpress, dry-offset, and rotary silk screen printing plates. Established in 2005 and based in Kefar Sava, Israel, the company offers an inkjet-based computer-to-plate (CtP) solution that enhances the quality of analog printing plates while streamlining the production process. DigiFlex’s technology eliminates the need for traditional film and chemical processing, allowing users to manage the entire plate-making process in-house. This capability not only improves efficiency but also reduces costs for narrow web application printers. DigiFlex’s products are distributed across Europe, North America, the Far East, and other international markets. As of late 2017, DigiFlex operates as a subsidiary of P.V. Nano Cell Ltd.

Vayar Vision Ltd. is a technology company based in Haifa, Israel, established in 2007. It specializes in developing a visual search engine that enhances the search capabilities of textual search engines and enables users to find information through images. The company's technology allows users to search large databases and the web for similar images, facilitating access to relevant visual content. Vayar's solutions cater to various sectors, providing tools for image banks with copyright protection, supporting homeland security and law enforcement in crowd analysis, and assisting in medical diagnostics by matching imaging data with medical literature. Additionally, Vayar integrates its visual search results with decision support systems, enhancing the way users discover and interact with visual information. The company aims to bridge the gap between images and textual information, creating a more intuitive search experience.

Leadspace is a provider of a B2B Customer Data Platform designed to enhance sales and marketing efforts. The company's platform integrates first-party customer data with third-party data, intent signals, and artificial intelligence to deliver a comprehensive view of customers and prospects. This enables organizations to identify ideal customers and recommend targeted marketing and sales activities. By streamlining access to vital sales and marketing data, Leadspace empowers clients to engage effectively with their audiences, driving growth and improving customer engagement across various channels.

APProtect Ltd. provides anti-piracy protection solutions for consumer and business software developers and publishers. It offers Trusted Server Protection products to protect CAD tools and scientific applications in companies, universities, and other organizations; Online Software Protector family of products for protecting consumer software; and splitting machine software, which operates on a binary and splits it into two parts. The company also provides splitting, site installation, and server hosting services. APProtect Ltd. was founded in 2004 and is based in Haifa, Israel.

GeneGrafts Ltd., also known as GreenGrafts Ltd., is a biotechnology company based in Haifa, Israel, specializing in the development of therapeutic products aimed at treating conditions such as cardiac arrhythmia, Parkinson's disease, and epilepsy. Founded in November 2003, the company has established a proprietary technology platform that employs cell therapy to modulate excitable tissues in the brain and heart. This innovative approach involves the transplantation of cell grafts derived from the patient's own body, which define the ion channels necessary for integrating with the target organ. By doing so, GeneGrafts seeks to alter the electrical properties of these organs in a controlled manner, providing a promising new avenue for the treatment of various neurological disorders and cardiac conditions.